Related references
Note: Only part of the references are listed.Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing
Vidya Balagopal et al.
PLOS ONE (2019)
Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
Oliver Tunstall et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
Marius Flasinski et al.
BLOOD ADVANCES (2018)
GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia
Irene Roberts et al.
BLOOD (2013)
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia
Kate A. Alford et al.
BLOOD (2011)
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
Alan S. Gamis et al.
BLOOD (2011)
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia
Rika Kanezaki et al.
BLOOD (2010)
Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
Jan-Henning Klusmann et al.
BLOOD (2008)
Risk factors for early death in neonates with Down syndrome and transient leukaemia
Hideki Muramatsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Incidence and clinical implications of GATA1mutations in newborns with Down syndrome
Sharon R. Pine et al.
BLOOD (2007)
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
Gita V. Massey et al.
BLOOD (2006)
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts
C Langebrake et al.
KLINISCHE PADIATRIE (2005)
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
G Mundschau et al.
BLOOD (2003)
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
J Wechsler et al.
NATURE GENETICS (2002)
Share Paper
